Elevar Therapeutics Announces Promotion of Mark Gelder, M.D. to Chief Medical Officer
SALT LAKE CITY, USA., January 12, 2021 — Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, announced today that Mark Gelder, M.D., has been promoted to